SG11202103389WA - Immunogenic compositions - Google Patents
Immunogenic compositionsInfo
- Publication number
- SG11202103389WA SG11202103389WA SG11202103389WA SG11202103389WA SG11202103389WA SG 11202103389W A SG11202103389W A SG 11202103389WA SG 11202103389W A SG11202103389W A SG 11202103389WA SG 11202103389W A SG11202103389W A SG 11202103389WA SG 11202103389W A SG11202103389W A SG 11202103389WA
- Authority
- SG
- Singapore
- Prior art keywords
- immunogenic compositions
- immunogenic
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
- A61K39/0018—Combination vaccines based on acellular diphtheria-tetanus-pertussis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/5555—Muramyl dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18204691 | 2018-11-06 | ||
| PCT/EP2019/080120 WO2020094580A1 (fr) | 2018-11-06 | 2019-11-04 | Compositions immunogènes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202103389WA true SG11202103389WA (en) | 2021-05-28 |
Family
ID=64456746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202103389WA SG11202103389WA (en) | 2018-11-06 | 2019-11-04 | Immunogenic compositions |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20230201325A1 (fr) |
| EP (1) | EP3876982A1 (fr) |
| JP (1) | JP7469302B2 (fr) |
| KR (1) | KR20210090646A (fr) |
| CN (1) | CN112996538A (fr) |
| AR (1) | AR117191A1 (fr) |
| AU (1) | AU2019376832B2 (fr) |
| BR (1) | BR112021007668A2 (fr) |
| CA (1) | CA3117867A1 (fr) |
| EA (1) | EA202190914A1 (fr) |
| IL (1) | IL282753A (fr) |
| MX (1) | MX2021005303A (fr) |
| SG (1) | SG11202103389WA (fr) |
| WO (1) | WO2020094580A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022123063A2 (fr) | 2020-12-11 | 2022-06-16 | Glaxosmithkline Biologicals Sa | Bactéries à hyper-boursouflure |
| GB202211033D0 (en) | 2022-07-28 | 2022-09-14 | Glaxosmithkline Biologicals Sa | Purification process |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2848965A1 (de) | 1978-11-11 | 1980-05-22 | Behringwerke Ag | Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine |
| DE69022106T2 (de) | 1989-04-28 | 1996-02-15 | Sclavo Spa | Pertussistoxin-Mutanten, dieselbe produzierende Bordetella-Stämme und ihre Verwendung als Vakzin gegen Pertussis. |
| WO2000023105A2 (fr) | 1998-10-16 | 2000-04-27 | Smithkline Beecham Biologicals S.A. | Produits d'addition et vaccins |
| ATE276199T1 (de) | 1999-02-03 | 2004-10-15 | Biosante Pharmaceuticals Inc | Methoden zur herstellung von therapeutische kalzium-phosphat partikeln |
| EP1034792A1 (fr) | 1999-03-11 | 2000-09-13 | Pasteur Merieux Serums Et Vaccins | Administration par voie intranasale de vaccins à base de polyosides de Pneumococcus |
| FR2791895B1 (fr) | 1999-03-23 | 2001-06-15 | Pasteur Merieux Serums Vacc | Utilisation de trehalose pour stabiliser un vaccin liquide |
| WO2001041800A2 (fr) | 1999-12-02 | 2001-06-14 | Chiron Corporation | Compositions et procedes de stabilisation de molecules biologiques lors dune operation de lyophilisation |
| NO20002828D0 (no) | 2000-06-02 | 2000-06-02 | Statens Inst For Folkehelse | Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav |
| RU2323002C2 (ru) | 2001-07-26 | 2008-04-27 | Чирон Срл. | Вакцины, содержащие алюминиевые адъюванты и гистидин |
| DK2255826T3 (en) * | 2002-08-02 | 2016-06-20 | Glaxosmithkline Biologicals Sa | Neisserial vaccine compositions comprising a combination of antigens. |
| GB0220194D0 (en) | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
| GB0316560D0 (en) | 2003-07-15 | 2003-08-20 | Chiron Srl | Vesicle filtration |
| CN104024400B (zh) * | 2011-12-21 | 2018-02-16 | 亚洲生物网有限公司 | 经修饰的百日咳博德特氏菌菌株 |
| KR20150073160A (ko) * | 2012-10-03 | 2015-06-30 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 면역원성 조성물 |
| US8916173B2 (en) * | 2013-03-08 | 2014-12-23 | Crucell Holland B.V. | Acellular pertussis vaccine |
| AR090538A1 (es) * | 2013-03-27 | 2014-11-19 | Consejo Nac Invest Cient Tec | Vacuna para la prevencion de infecciones con bordetella |
| CA2919773A1 (fr) * | 2013-08-05 | 2015-02-12 | Glaxosmithkline Biologicals S.A. | Compositions immunogenes en combinaison |
-
2019
- 2019-11-04 WO PCT/EP2019/080120 patent/WO2020094580A1/fr unknown
- 2019-11-04 SG SG11202103389WA patent/SG11202103389WA/en unknown
- 2019-11-04 AU AU2019376832A patent/AU2019376832B2/en active Active
- 2019-11-04 JP JP2021523667A patent/JP7469302B2/ja active Active
- 2019-11-04 EP EP19805546.9A patent/EP3876982A1/fr active Pending
- 2019-11-04 EA EA202190914A patent/EA202190914A1/ru unknown
- 2019-11-04 US US17/287,268 patent/US20230201325A1/en active Pending
- 2019-11-04 CA CA3117867A patent/CA3117867A1/fr active Pending
- 2019-11-04 AR ARP190103212A patent/AR117191A1/es unknown
- 2019-11-04 CN CN201980072018.3A patent/CN112996538A/zh active Pending
- 2019-11-04 BR BR112021007668-9A patent/BR112021007668A2/pt unknown
- 2019-11-04 KR KR1020217016698A patent/KR20210090646A/ko unknown
- 2019-11-04 MX MX2021005303A patent/MX2021005303A/es unknown
-
2021
- 2021-04-28 IL IL282753A patent/IL282753A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3876982A1 (fr) | 2021-09-15 |
| AU2019376832A1 (en) | 2021-05-13 |
| IL282753A (en) | 2021-06-30 |
| EA202190914A1 (ru) | 2021-08-03 |
| KR20210090646A (ko) | 2021-07-20 |
| CN112996538A (zh) | 2021-06-18 |
| JP7469302B2 (ja) | 2024-04-16 |
| CA3117867A1 (fr) | 2020-05-14 |
| BR112021007668A2 (pt) | 2021-07-27 |
| JP2022506347A (ja) | 2022-01-17 |
| WO2020094580A1 (fr) | 2020-05-14 |
| US20230201325A1 (en) | 2023-06-29 |
| MX2021005303A (es) | 2021-07-07 |
| AR117191A1 (es) | 2021-07-21 |
| AU2019376832B2 (en) | 2024-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201811312D0 (en) | Compositions | |
| GB2586745B (en) | Compositions | |
| SG11202010821TA (en) | Vaccine composition | |
| SG11202009259VA (en) | Compositions | |
| GB201802339D0 (en) | Immunogenic composition | |
| GB201711635D0 (en) | Immunogenic composition | |
| SG11202104306XA (en) | Compositions | |
| IL274975A (en) | Preparations that stimulate the immune system | |
| GB201711637D0 (en) | Immunogenic composition | |
| GB201803923D0 (en) | Compositions | |
| IL291559A (en) | Immunogenic preparations | |
| GB2562241B (en) | Vaccine compositions | |
| SG11202009147UA (en) | Vaccine compositions | |
| IL282753A (en) | Immunogenic compounds | |
| IL271603A (en) | Immunogenic preparations | |
| GB201604755D0 (en) | Immunogenic compositions | |
| GB201803692D0 (en) | Immunogenic composition | |
| GB201819206D0 (en) | Novel compositions | |
| EP3710051A4 (fr) | Compositions de vaccin | |
| GB2570649B (en) | Compositions | |
| GB201805676D0 (en) | Compositions | |
| GB201820010D0 (en) | Immunogenic composition | |
| GB201809541D0 (en) | Vaccine compositions | |
| GB201805393D0 (en) | Vaccine compositions | |
| ZA202005658B (en) | Compositions |